Open access
Oct 2026
Short-term side effects of first bisphosphonate infusion in children with different underlying bone pathologies.
BACKGROUND Intravenous bisphosphonates are the primary pharmacological intervention for both primary and secondary paediatric osteoporosis. Following the successful use of bisphosphonates in children with osteogenesis imperfecta (OI), indications have expanded to a broad range of bone pathologies with variable underlyi...
A. Raimann, W. Högler, Elisabeth Laurer et al.
· Hormone Research in Paediatr... · 0 citations